Peptide hormones abuse in sport: State of the art in the detection of growth hormone and erythropoietin

Journal of Toxicology - Toxin Reviews

Volumn 18, Issue 2, 1999, Pages 145-176

  Rivier, Laurent ^a   Saugy, Martial ^a  

^a UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE HORMONE; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GROWTH HORMONE;

BLOOD ANALYSIS; BLOOD SAMPLING; DOPING; DRUG ABUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHICS; HUMAN; LABORATORY; LEGAL ASPECT; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHYSICAL PERFORMANCE; RADIOIMMUNOASSAY; REVIEW; SCREENING TEST; URINALYSIS;

EID: 0033007019     PISSN: 07313837     EISSN: None     Source Type: Journal    
DOI: 10.3109/15569549909016463     Document Type: Review

References (63)

1. Council of Europe (1997) Report from the 8th meeting of the following-up group belonging to the Anti-doping convention. Document T-DO (97) 22rÇv.
2. Cowart V.S. (1988) Human growth hormone, the latest ergogenic aid? Physician Sports Medicine 16, 175-185.
3. Macintyre J.G. (1987) Growth Hormone and the Athletes. Sports Med. 4, 129-142.
4. Christ D.M., Peake G.T., Egan P.A. and Waters D.L. (1988) Body composition response to exogenous GH during training of highly conditioned adults. J. Appl. Physiol. 67, 54-61.
5. Christiansen J.S., Jorgensen J.O., Pedersen S.A., Moller J., Jorgensen J. and Skakkboek N.E. (1990) Effects of growth hormone on body composition in adults. Hormone Res. 33, suppl. 4, 61-64.
6. Cuneo R.C., Solomon F., Wiles M. and Snksen P.H. (1990) Skeletal muscle performance in adults with growth hormone deficiency. Hormone Res. 33, suppl. 4, 55-60.
7. Duchaine D. (1989) Human Growth Hormone. In: Underground Steroid Handbook II California: HLR Technical Books, 74-76.
8. Rogol A.D. (1989) Growth Hormone: Physiology, therapeutic use and potential for abuse. Exerc. Sport Sci. Rev. 17, 353-377.
9. Darendelier F., Hindmarsh P.C. and Brook C.G.D. (1990) Non-conventional use of growth hormone: European experience. Hormone Res. 33, 128-136.
10. Baumann G. and Abramson E.C. (1983) Urinary growth hormone in man: evidence for multiple molecular forms. J. Clin. Endocrinol. Metab. 56, 305-311.
11. Hattori N., Shimatsu A., Kato Y. et al. (1989) Urinary excretion of human growth hormone: daily variation and relationship with albumin and alpha-one-microglobulin in urine. Acta Endocrinol. (Copenhagen) 121, 533-537.
12. Saugy M., Cardis Ch., Caron M. J., Gomez F., Landolt S. and Rivier L. (1994) Urinary human growth hormone (U-HGH): Alternative to hGH blood test in doping controls? In: Hemmersbach P. and Birkeland KL, Edits (1994) Blood samples in doping control. Proceedings of the second international symposium on drugs in sports: Towards the use of blood samples in doping controls? Lillehammer, Norway, August 29-31, 1993. Oslo: On Demand Publishing, 53-64.
13. Rivier L. Saugy M. and Cardis C. (1995) Endogenous doping agents detection: State-of-the-art and new strategies as demonstrated by the growth hormone problem. In: Aspects on Forensic Toxicology. Kovatsis A.V. et Tsoukali-Papadopoulou H. (Edits) Thessaloniki: Erasmos,. 83-87.
14. Saugy M. Cardis C. and Rivier L. (1995) Urinary human growth hormone (U-hGH) I. Measurements in non-athlete volunteers after intra-muscular or subcutaneous hGH injections. In: Recent Advances in Doping Analysis Vol. 2. M. Donike, H. Geyer, A. Gotzmann and U. Mareck-Engelke (Edits).Koln: Sport und Buch Strauss, 213-222.
15. Saugy M., Cardis C., Rivier L., Brisson G., Ayotte C., Hemmersbach P. Haug E. and Segura J. (1995) Urinary human growth hormone (U-hGH) II. Measurements in competition tests. More the expression of the renal function than the endocrinological status. In: Recent Advances in Doping Analysis Vol. 2. M. Donike, H. Geyer, A. Gotzmann and U. Mareck-Engelke (Edits).Koln: Sport und Buch Strauss, 223-234.
16. Saugy M., Cardis Ch., Schweizer C., Veuthey J.-L. and Rivier L. (1996). The detection of human growth hormone doping in urine: Out of competition tests are necessary. Journal of Chromatogr B, Special issue: Doping control. 687, 201-211.
17. Schweizer C, Cardis C., Cauderay M., Rivier L., Saugy M. (1997) T/E ratio variation through puberty in male adolescents. Proceedings of the 12th Cologne (1996) workshop on dope analysis. In: Recent Advances in Doping Analysis Vol. 4, W. Schaenzer, H. Geyer, A. Gotzmann and U. Mareck-Engelke (Edits).Koln: Sport und Buch Strauss, 159-171.
18. Garreau G., Audran M., Baynes R.D., Flowers C.H., Duvallet A. Senecal L. and Brisson G (1996) Erythropoietin abuse in athletes. Nature 380, #6570, 113.
19. Caro J Schuster S Ramirez S (1991) The regulation of erythropoietin gene expression. In: AJ Erslev JW Adamson JW Eschbach CG Winearis. Erythropoietin molecular, cellular and clinical biology. Baltimore: Johns Hopkins Univ. Press, Chapter 4, 53-64.
20. Egrie J Browne JK (1991) The molecular biology of erythropoietin. In: AJ Erslev JW Adamson JW Eschbach CG Winearis. Erythropoietin molecular, cellular and clinical biology. Baltimore: Johns Hopkins Univ. Press, Chapter 2, 211-240.
21. Schuster SJ Wilson JH Erslev AJ et al. (1987) Physiologic regulation and metabolism of erythropoietin. Blood 70, 316-318.
22. Conconi F Casoni I Manfredini F Mayyoni G Grazzi G Guglielmini C Ballarin E Borsetto C Buzzoni D Guerra G Ricci G Dapporto M Rigolin I (1990) Detection of erythropoietin administration in sports. In: Hemmersbach P. and Birkeland KL, Edits (1994) Blood samples in doping control. Proceedings of the second international symposium on drugs in sports: Towards the use of blood samples in doping controls? Lillehammer, Norway, August 29-31, 1993. Oslo: On Demand Publishing, 133-140.
23. Berglund B Hemmingsson P (1987) Int. J. Sports Med. 8, 231-233.
24. Schmidt WK Weiglein K (1996). Int. J. Sports Med 17 (suppl1) S23.
25. Spivak JL Cotes PM (1991) The pharmacology and metabolism of erythropoietin. In: AJ Erslev JW Adamson JW Eschbach CG Wineris. Erythropoietin molecular, cellular and clinical biology. Baltimore: Johns Hopkins Univ. Press, Chapter 10, 162-183.
26. Cotes PM Spivak JL (1991) Erythropoietin in health and disease. In: AJ Erslev JW Adamson JW Eschbach CG Winearis. Erythropoietin molecular, cellular and clinical biology. Baltimore: Johns Hopkins Univ. Press, Chapter 11, 184-207.
27. Erslev AJ (1991) Erythropoietin. New Eng. J Med. 324, 1339-1344.
28. Berglund B Ekblom B (1991) Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men. J. Internal Med. 229, 125-130.
29. Vauthers JP (1990) Erythropoietine recombinante humaine: de la clinique ‡ la physiopathologie de l'anÈmie de l'insuffisance rÈnale. Revue MÈd. Suisse romande 110, 951-954.
30. Mandin H (1990) Erythropoietin as possible substance for blood doping. In: Bellotti P Benzi G Ljungqvist, Official proceedings, 2nd I.A.F. World Symposium on Doping in Sport, International Athletic Foundation, Monte Carlo, 5-7 June 1989, Monte Carlo: International Athletic Foundation, 13-30.
31. Tanabe M Teshima S Hanyu T Hayashi Y (1992) Rapid and sensitive method for Erythropoietin determination in serum. Clin Chem 38, 1752-1755.
32. Wide L Bengtsson C (1990) Molecular charge heterogeneity of human serum Erythropoietin. Br. J. Haematol. 76, 121-127.
33. Adamson J.W. and Vapnek D. (1991) Recombinant erythropoietin to improve athletic performance. The New England J. Med. 324, 698-699.
34. Ekblom B. and Berglund B. (1991) Effect of erythropoietin administration on maximal aerobic power. Scand J. Med. Sci. Sports 1, 88-93.
35. Walder G.I. and Hainline B. (1989) Blood doping and erythropoietin. In: A.J. Ryan ed. Drugs and the Athlete. Philadelphia: F.A. Davis, 172-177.
36. Berglund B. (1988) Development of techniques for the detection of blood doping in sport. Sports Med. 5, 127-135.
37. Berglund B. (1996) Blood doping and erythropoietin. The effects of variation in haemoglobin concentration and other related factors on physical performance. Am. J. Sports Med. 24, S40-S42.
38. Wide L. (1995) Detection in blood and urine of recombinant erythropoietin administered to healthy men. Med Sci Sports Exerc. 27, 1569-1576.
39. Salomonson T., Danielson B.G., Wikstrom B. (1990) The pharmacokinetic of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects. Br J Clin Pharmacol. 29, 709-713.
40. Garreau G., Brisson G.R., Chenard C., Gagnon M.G., Richalet J.P. and Audran M. (1995) Discrimination possible entre entraonement en altitude et dopage l'ÈrythropoiÈtine. Sci. et Sports 10, 81-82.
41. Saugy M., Cardis C., Cauderay M., Schweizer C, Robinson N., Rivier L. and Mangin P. (submitted) One year experience of haematocrit measurements in professional cycling: preventive approach for an acute doping problem. Proceedings of the 14th Cologne (1998) workshop on dope analysis. In: Recent Advances in Doping Analysis Vol. 6, W. Schaenzer, H. Geyer, A. Gotzmann and U. Mareck-Engelke (Edits).Kln: Sport und Buch Strauss.
42. Garreau R Audran M et al.. (1996) Nature 380, 113.
43. Casoni I Ricci G Ballarin E (1993) Haematological indices of erythropoietin administration in athletes. Int. J. Sports Med. 14, 307-311.
44. Bowers L.D. and Borts D.J. (1997) Evaluation of selected-ion storage ion-trap mass spectrometry for detecting urinary anabolic agents. Clin. Chem,. 43, 1033-1039.
45. Lau B.P.-Y., Lewis D. and Lawrence J.F. (1997) Confirmation analysis of clenbuterol in beef liver and minced beef by a combination of immunoaffinity chromatography and liquid chromatography/electrospray mass spectrometry or liquid chromatography / electrospray tandem mass spectrometry. J. Mass Spectrom. 32, 655-661.
46. Rizea Savu S., Silvestro L., Haag A. and Soergel F. (1996) A confirmatory HPLC-MS/MS method for ten synthetic corticosteroids in bovine urines, J. Mass Spectrom. 31, 1351-1363.
47. Bowers L.D. and Borts D.J.(1996) Separation and confirmation of anabolic steroids with quadrupole ion trap tandem mass spectrometry. J Chromatogr. B 687, 69-78.
48. Arcelloni C., Fermo I., Banfi G., Pontiroli A.E. and Paroni R. (1993) Capillary electrophoresis for protein analysis: separation of human growth hormone and human insulin molecular forms. Anal. Biochem. 212, 160-167.
49. Kabouris M., Platen P. and Donike M. (1996) Detection of human growth hormone in urine of athletes. In: Recent Advances in Doping Analysis Vol. 3. M. Donike, H. Geyer, A. Gotzmann and U. Mareck-Engelke (Edits). Kln: Sport und Buch Strauss, 313-323.
50. Ellis J.D., Hand E.L. and Gilbert J.D. (1997) Use of LC-MS/MS to cross-validate a radioimmunoassay for the fibrinogen receptor antagonist, Aggrastat (tirofiban hydrochloride) in human plasma. J. Pharmaceut. Biochem. Anal. 15, 561-569.
51. Roberts N.B., Green B.N. and Morris M. (1997) Potential of electrospray mass spectrometry for quantifying glycohaemoglobin. Clin. Chem. 43, 771-778.
52. Boss H.J., Rohde M.F. and Rush R.S. (1995) Multiple sequential fraction collection of peptides and glycopeptides by high-performance capillary electrophoresis. Ana. Biochem. 230, 123-129.
53. Liu CL., Muddiman D.C., Tang K., Smith R.D. (1997) Improving the microdialysis procedure for electrospray ionisation mass spectrometry of biological samples. J. Mass Spectrom. 32, 425-431.
54. Jansson C., Boguszewski C., Rosberg S., Carlson L., Albertsson-Wikland K. (1997) Growth hormone (GH) assays: influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein. Clin. Chem. 43, 950-956.
55. Tang Q., Harrata K and Lee C.S. (1996) Comparison of protein separation in capillary zone electrophoresis and capillary isoelectric focusing interfacing with electrospray mass spectrometry. J. Mass Spectrom. 31, 1284-1290.
56. Jespersen S., Koedam J.A., Hoogerbrugge C.M., Tjaden U.R., van der Greef J., Van den Brande J.L. (1996) Characterisation of O-glycosylated precursors of insulin-like growth factor II by Matrix-assisted laser desorption/ionisation mass spectrometry. J. Mass Spectrom. 31, 893-900.
57. Liu CL and Bowers L.D. (1997) Mass characterisation of the beta-subunit of human chorionic gonadotropin. J. Mass Spectrom. 32, 33-42.
58. Nieto O., Hernandez P. and Hernandez L. (1996) Capillary Zone Electrophoresis of human recombinant erythropoietin using C8 coated columns without additives in the running buffer. Anal. Comm. 33, 425-427.
59. Bowers L.D. (1997) Analytical advances in detection of performance-enhancing compounds. Clinical Chem. 43, 1299-1304.
60. Bower L.D., Fregien K. (1994) HPLC/MS confirmation of peptide hormones in urine: evaluation of limit of detection. In: Donike M. et al. Edits. Vol. 3, Recent advances in doping analysis (1). Kln: Sport und Buch Strauss, 175-184.
61. Lam C.W., Lawson A.M. and Hjelm N.M. (1997) Electrospray Mass Spectrometry of proteins in biomedicine. J Intern. Fed. Clinical Chem. 9, 72-75.
62. Liu C. and Bowers L.D. (1996) Immunoaffinity trapping of urinary human chorionic gonadotropin and its high performance liquid chromatographic - mass spectrometric confirmation. J. Chromatogr. B 687, 213-220.
63. Linsley K.B., Chan S.Y., Chan S., Reinhold B.B., Lisi P.J. and Reinhold V.N. (1994) Applications of electrospray mass spectrometry erythropoietin N-and O-linked glycans. Anal. Biochem 219, 207-217.